Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era

Kapila N, Al-Khalloufi K, Bejarano PA, Vanatta JM, Zervos XB. Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era. Am J Transplant. 2019;:Aug 26. doi: 10.1111/ajt.15583. [Epub ahead of print].

Publication Type:

Journal Article

Authors:

Kapila, N; Al-Khalloufi, K; Bejarano, PA; Vanatta, JM; Zervos, XB

Source:

Am J Transplant, p.Aug 26. doi: 10.1111/ajt.15583. [Epub ahead of print] (2019)

Cited On:

Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors

Export Citation:

RIS Format

Top